FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Qingdao BAHEAL Pharmaceutical Co., Ltd.)

View source ↗

Summary

The FDA approved Qingdao BAHEAL Pharmaceutical Co., Ltd.'s metformin hydrochloride extended-release tablets under an Original Application (ANDA 209993).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Metformin Hydrochloride Extended-release Tablets (metformin hydrochloride extended-release)

Snippet

ORIG AP for METFORMIN HYDROCHLORIDE (METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS)